STOCK TITAN

Cbd Denver Inc - CBDD STOCK NEWS

Welcome to our dedicated page for Cbd Denver news (Ticker: CBDD), a resource for investors and traders seeking the latest updates and insights on Cbd Denver stock.

CBD of Denver, Inc. (CBDD) is a company based in Denver, Colorado, focused on acquiring profitable assets to create value for shareholders. The company has two key subsidiaries, Luxora and Libra 9 GmbH, with diverse revenue streams. Luxora Solutions specializes in offering infrastructure solutions to cannabis clubs in Germany, providing production units and consulting services. On the other hand, Libra 9 GmbH offers innovative consumer products like the Magic Lappen and the BerlinR13 Anti-Slip solution. The recent financial results for CBD of Denver Inc. have shown significant improvements in revenue, operational efficiency, and strategic achievements, with Luxora reporting substantial growth and contributing significantly to the company's overall revenue. The company recently made the decision to unwind the acquisition of Libra 9 GmbH due to unmet revenue goals and evolving market conditions. Axel Reinke, the former CEO, has resigned, and Jan Schwager, Luxora's CEO, has taken over the role. Luxora Inc. has been experiencing remarkable growth, engaging in strategic partnerships and signing an LOI with CheckMyWeed to launch a new product called CheckMyWeed powered by NIRLAB, aiming to revolutionize cannabinoid content analysis in cannabis flowers. Additionally, Luxora is capitalizing on the upcoming changes in German cannabis laws to expand its market reach and explore new growth opportunities.

Rhea-AI Summary
CBD of Denver, Inc. announces acquisition of HOLISTICH GmbH, expanding into European market. HOLISTICH adds revenue and strong relationships with shipping companies. Luxora generates $468,000 in revenue. No immediate impact on stock price expected.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
14.29%
Tags
-
Rhea-AI Summary
Year Over Year Gross Profit increased from a loss of $165,232 to a profit of $173,262. Revenue increased 155% to $729,453 for Q2 2023. Net loss reduced by $440,445 to $9,701 for Q2 2023. The company successfully launched The Magic Lappen with Libra 9 GmbH and expanded its retailer network to 180 EDEKA stores. Signed an agreement with LUXORA LLC for distribution of Cannabis products. Positive outlook with preparation of factsheets and group management meeting next week.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
-
Rhea-AI Summary
CBD of Denver, Inc. (OTC Pink: CBDD) will host an Investor Relations conference call on August 17, 2023. The call will cover an overview of Berliner and Luxora, current filings and listing status, and a Q&A session. CEO Axel Reinke, CEO Jan Schwager, and Board Directors Robert Roever and Nicholas Sprung will be on the call.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
16.67%
Tags
none
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
20%
Tags
none
-
Rhea-AI Summary
CBD of Denver (CBDD) has entered into an agreement to acquire LUXORA Holding AG, a leader in the CBD Wholesale market. The company has created a new subsidiary, LUXOA LLC, to combine its existing wholesale CBD flower business with that of LUXORA. LUXORA Holding AG is positioned to revolutionize the dynamics of cannabis operations across Europe, with a product portfolio including distribution and resale rights for distinguished brands such as Weedo, Hempcrew, Happybuds, and Mydarling. LUXORA is strategically positioning its German division to leverage the forthcoming approval of legislation creating the framework for Germany's journey towards cannabis legalization. The company aims to capture 2% of the potential 13,000 Cannabis Clubs in Germany, offering Plug & Play solutions that allow clubs to produce for a maximum cost of €3 per gram. Backed by a collective experience of nearly 100 years, LUXORA's dedicated team comprises seasoned experts who have overseen successful management of production and distribution, and operated social clubs in Ibiza and Barcelona. CEO Jan Schwager emphasizes the company's commitment to delivering substantial value to the company, its shareholders, and the cannabis industry as a whole. The acquisition of LUXORA Holding AG by CBDD marks a pivotal moment in the evolution of the European cannabis market, poised to drive unprecedented growth, introduce premium products, and contribute to the establishment of a thriving, regulated cannabis industry in Europe.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
25%
Tags
-
Rhea-AI Summary
CBDD - CBD of Denver Announces Q2 Top Line Growth and Magic Lappen Rollout, Shareholder Call Scheduled - Denver, Colorado--( - August 7, 2023) - CBD of Denver (OTC Pink: CBDD) is pleased to report another quarter of top line growth, with Q2 expected to be approximately 600k, compared to 259k in Q1 2023, 113k in Q4 2022, and 26k in Q3 2022. The company also announced the rollout of the Magic Lappen and scheduled a shareholder call. Despite a loss for the quarter, it is substantially smaller than previous quarters.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary
CBD of Denver (OTC Pink: CBDD) has filed with FINRA to change its name to Berliner Innovations and increased the number of authorized shares to 7 billion. Paul Gurney has resigned from the board. The company is expanding the roll out of the Magic Lappen to Edeka stores throughout Germany, aiming to reach 600 locations. The Anti Slip division has had its best 1 day sign up with 10 new business opportunities. The company's wholesale CBD business has experienced consecutive quarter-over-quarter growth for the past three quarters. Germany is in the process of legalizing cannabis. The Shareholder Update Call has been postponed due to CEO Axel Reinke's illness.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-25%
Tags
none
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none
Rhea-AI Summary

CBD of Denver, Inc. (OTC: CBDD) reported February 2021 revenues of CHF 2,338,185 (approximately USD 2,572,895), showcasing resilience amid ongoing European lockdowns. Despite travel restrictions impacting customer access and delayed orders, the company achieved increased sales compared to January 2021. CEO Marcel Gamma credited their sales team's effective customer management for maintaining loyalty. CBDD aims to expand through acquisitions of profitable Swiss assets while prioritizing quality products and strong customer relationships.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.56%
Tags
none

FAQ

What is the current stock price of Cbd Denver (CBDD)?

The current stock price of Cbd Denver (CBDD) is $0.0001 as of February 28, 2025.

What is the market cap of Cbd Denver (CBDD)?

The market cap of Cbd Denver (CBDD) is approximately 1.5M.

What is CBD of Denver, Inc. focused on?

CBD of Denver, Inc. aims to acquire profitable assets at attractive valuations to create value for its shareholders.

What are the key subsidiaries of CBD of Denver, Inc.?

The company's key subsidiaries are Luxora and Libra 9 GmbH, with Luxora focusing on providing infrastructure solutions to cannabis clubs and Libra 9 GmbH offering consumer products like Magic Lappen.

What recent achievements have been reported by CBD of Denver, Inc.?

Recent financial results for the company have shown significant improvements in revenue, operational efficiency, and strategic achievements. Luxora has been instrumental in driving revenue growth for the company.

Why did CBD of Denver, Inc. decide to unwind the acquisition of Libra 9 GmbH?

The decision to unwind the acquisition was made due to unmet revenue goals and evolving market conditions, prompting the company to reallocate resources and focus on more profitable ventures.

Who is the new CEO of CBD of Denver, Inc.?

Jan Schwager, the CEO of Luxora, has been appointed as the new CEO of CBD of Denver, Inc., following the resignation of Axel Reinke.

What strategic partnership has Luxora Inc. recently engaged in?

Luxora Inc. has signed an LOI with CheckMyWeed to launch a new product called CheckMyWeed powered by NIRLAB, revolutionizing cannabinoid content analysis in cannabis flowers.

How is Luxora Inc. leveraging the upcoming changes in German cannabis laws?

Luxora Inc. is capitalizing on the upcoming changes in German cannabis laws to expand its market reach, explore new growth opportunities, and stay ahead of the evolving regulatory landscape.
Cbd Denver Inc

OTC:CBDD

CBDD Rankings

CBDD Stock Data

1.51M
7.55B
0%
Drug Manufacturers - Specialty & Generic
Healthcare
Link
United States
Centennial